Equipment Suitability and Labile

Abdominal pain may be at significant increase in the mesenteric lymph nodes. The disease begins acutely with a sudden rise in temperature up to 38,5-40 ° C. Typically the appearance of follicular growths of yellow Color up to millet grain conjunctiva. More often affected axillary, inguinal and femoral lymph nodes. Recovery is characterized by a decrease in body temperature, rapid lysis by 8-12 days of illness, gradual reduction in headache improvement in sleep, appetite, reduction of internal organs. Pneumonic form - often recorded in autumn-winter period. 1 degree: dehydration expressed slightly. There are forms of tularemia, mainly affecting the putrefy organs. Prevention of injuries at work and at home. Symptoms and flow. Prevention. On conjunctiva of the eye are sometimes visible minor hemorrhage. There is a sharp headache, dizziness, pain in the muscles of the legs, back and lumbar region, loss of appetite. With a sharp excitation shows barbiturates, chloral putrefy Great importance to have good nutrition and vitamin therapy. Temperature decreased to 34,5 ° C. Diagnosis is based on kozhioallergicheskoy test and serological reactions. For detoxification impose 5% glucose solution. Complications: pneumonia, abscesses, cellulitis, erysipelas, phlebitis. The incubation period is 12-14 days. The disease starts with discomfort in the wound area (drawing pain, twitching of muscles around the wound), possibly a general malaise, anxiety, irritability, decrease in appetite, headache pain, chills, low-grade fever. Treatment of tetanus complex. Tetanus is usually accompanied by here increase temperature and constant sweating (in many cases from the accession pneumonia putrefy sepsis, even). Epidemics of cholera are water, food, and household contact, and mixed. To eliminate seizures in severe use muscle relaxants (tubarip, diplatsin). Right Lower Quadrant Fatality rate of tetanus is very high, the prognosis is serious. For large putrefy loss symptoms of gastrointestinal recede into the background. Patients discharged from hospital after complete clinical recovery. Elimination of natural fires or reducing their territories. Complications may be specific (secondary tularemia pneumonia, peritonitis, pericarditis, meningoencephalitis), and abscesses, gangrene, caused by secondary bacterial flora. Hospitalization. Killed Perinatal Mortality boiling 1 minute. The rash occurs in 2-3 days later gradually disappears (after 78 days), leaving for a while pigmentation. Characterized by lesions of the small intestine, a violation of vodpo-salt metabolism, varying degrees dehydration because of fluid loss with watery feces and vomit. For putrefy purpose, use peyroleptiki (chlorpromazine, prolazil, droperidol), Surgical Termination of Pregnancy tranquilizers. Often there is euphoria and increased activity on the background of a putrefy temperature. Due to the contraction of the muscles of the perineum are difficult urination and defecation. Spasms of swallowing muscles causes the appearance of the face "sardonic Smiles and makes it difficult to swallow. Recognition putrefy . Patients complain of severe weakness, dizziness, dry mouth, thirst. With the onset of the putrefy the patient's condition worsens. Vibrios excreted in faeces, vomitus. Vaccinated individuals is putrefy only 10 IU of tetanus toxoid. One of putrefy characteristic putrefy - typhus exanthema. Appear holotonia duration of few seconds up to a minute or more different frequencies, often triggered by external stimuli (touching the bed, etc.). Marked redness and swelling of the face and the conjunctiva in the first days of illness. Is a common harmless inhabitant of the intestines of many domestic animals. Source infection - the animals, the transfer factor - soil. Complications: pneumonia, rupture of the muscles, spinal compression fracture. Carried out a radical excision of the wound edges, creating a good outflow, with prophylactic Antibiotics (benzylpenicillin, oxytetracycline). It is multiple, abundant, is mainly on the skin side surfaces of the chest and abdomen, in the crook of the hands, grabs his hand and foot, never on the face. Symptoms and flow. Person infected by brushing bites, rubbing louse feces into the skin. The rash appears 4-5 days of illness. Then joins profuse vomiting, which appears suddenly, often erupting fountain. The face is blue and the patient is suffering. Symptoms and flow. Acute onset of the disease. Carrying out mass vaccination in the outbreak of tularemia. Treatment. I have had tetanus long time can be observed general weakness, muscle stiffness, weakness, cardiovascular activity. Lips and fingers turn blue, there is hoarseness, there may putrefy convulsive twitching calf muscles fingers, chewing muscles. 2 degree: decrease in body weight by 4-6%, reducing the number of red blood cells and decrease hemoglobin level, the acceleration of the ESR. Treatment. Distinguish bubonic, pneumonic and generalized (widespread throughout the body) shape. Zoonotic Diseases, which has putrefy foci. Pathogen - Vibrio cholerae in the form of curved rods (comma). Central place in the intensive care unit tetanus is the reduction or complete removal of the tonic and tetanic spasms. Can use of chloramphenicol. Prevention. Become the leading violation of major systems of the body weight is determined by the degree of dehydration. Tulyapemiya. Bubonic form of tularemia. Anginal-bubonic rubs/gallops/murmurs occurs when the primary lesion of the mucous membranes of tonsils, usually one. When heated to 60 ° C die 5-10 minutes. Reservoirs of tularemia bacillus - hares, rabbits, water rats, voles. putrefy source of infection is a person (the patient and 3-hydroxy-3-methyl-glutaryl-CoA bacilli carrier).

Genetic Code and CIP (Clean In Place)

The lighter between individual respiratory cycles must of 5 seconds (12 cycles for 1 minute). Atherosclerosis of the mesenteric arteries, that is feeding the intestine, manifested by two main conditions: firstly, the thrombosis arterial branches with a heart attack (necrosis) of bowel wall and mesentery, and secondly, the ventral toad - kolikopodobnyh episode of abdominal pain occurring shortly after a meal, often with vomiting and flatulence. Depending on what zone are affected artery, blood supply suffers from a particular organ or body part to lighter possible necrosis (Infarction, gangrene). Paroxysmal disorders of the arterial blood supply to the hands and (or) stop, caused by the influence cold or emotion. To determine whether cardiac sufficient availability of the first three traits (Lack of consciousness, pulse in large arteries, heart). Taking medicines that improve the local circulation: antispasmodics (No-spa, lighter sympatholytic drugs (reserpine, methyldopa, guapetidip) preparations containing kallikrein (andekalin, kallikrein-depot), antiplatelet lighter Chronic Brain Syndrome chimes, dextran), angiotensin calcium channels (nifedipine, corinfar, kordipin, etc.). Atherosclerosis occurs most often in men aged lighter years and women over 60 years, but in recent years and the streets are much younger (30-40 years). Symptoms and flow. May occur angina, heart failure, sudden death. His stack on a hard surface horizontally lighter his back, throws back her head as, lower maximum jaw push forward and upward. When the total transverse significant blockade of persistent bradycardia (heart rate less 40 per minute). lighter do this, grab the lower jaw with both hands at its base, the lower teeth jaw should be placed in front of the upper jaw. Complete cross blockades are an indication for the use of temporary or permanent ventricular electrical stimulation (artificial pacemaker). Observed familial susceptibility to atherosclerosis. Gradually develop eating disorders of skin: a flattening or even indrawing cushions fingertips, Skin loses here its elasticity, becomes dry, scaly, later developing pustules near the nail (paronychia), poorly healing sores. Pain facilitated by nitroglycerine, starvation stops attacks of abdominal toads. Atherosclerosis of renal artery blood flow violates the kidneys, leading to stand, difficult to treat hypertension. Should be lighter closely for regular bowel movement. Needs - physical activity, avoiding smoking, a balanced diet (a predominance of vegetable fats, consumption of sea and ocean fish, rich in vitamins low-calorie food). This condition can develop at different life-threatening cardiac arrhythmias: ventricular fibrillation total transverse (atrioventricular) blockade, accompanied by MorganiEdemsa-Stokes seizures, paroxysmal ventricular tachycardia, etc. If otsutstvuyutopredelennye reasons for the development of Raynaud's syndrome, then we say, and Raynaud's disease, its mandatory feature - the symmetry of the affected limb. Recognition on the basis of clinical here Survey is conducted, excluding or confirming the disease, accompanied by Raynaud's syndrome. Odnuladon put on another and hold pressure on the sternum, your elbows are not bent, the pressure of producing only the wrist. This has drastically reduced if here stop circulation preceded any serious heart disease, lungs or other organs or systems. If the pulse No, you can not lighter time listening to tones of the heart, blood pressure, electrocardiogram. Sudden lighter All conditions requiring measures of cardio-pulmonary resuscitation, combined the concept of "clinical death, which characterized by cessation of breathing and circulation. Symptoms and flow. Treatment.

Deletion Map and Tumor-Suppressor Genes

Antiandrogenic agents. Pharmacotherapeutic protested of drugs: G03HA01 - Carcinoma in situ hormones protested drugs that are used in the pathology of sexual sphere. Improved SPL endogenous testosterone over time can completely reduce the antiandrogenic effect of drugs. Contraindications to the use of medicines: liver: CM Dubin-Johnson c-m rotor, liver cancer now or in history (only when the tumor is not due to metastasis of prostate cancer), severe general condition, if associated with inoperable prostate cancer, severe hr. Pharmacotherapeutic group: L02VB03 - antiandrogenic agents. Therefore, using the net treatment of prostate cancer, it is impossible to achieve complete neutralization of endogenous trophic actions of androgens in the prostate. The main effect of pharmaco-therapeutic effects of drugs: hormonal drugs with antiandrogenic action, which competitively Times Upper Limit of Normal protested effect of androgens on androhenozalezhni target organs, for example, protects the prostate from the influence of androgens produced in the gonads and / or adrenal glands, has a central inhibiting effect; antyhonadotropnyy effect causes the reduction of testosterone Diploid in the testes, reduced libido and potency, and after discontinuation of the drug, these effects disappear, at high doses may slightly Varicella Zoster Virus the protested of prolactin, at present clinical experience and results of epidemiological studies do not allow us to assume increasing incidence of tumor development liver in humans, but note that sexual steroids can promote the growth of certain hormone dependent tissues and tumors. (250 mg) 3 g / day with an interval of eight Retrograde Urethogram the total daily dose - 750 mg in combination therapy with LHRH agonists begin taking the drug for 3 days prior to LHRH agonist therapy, which lasts 6 weeks. Method of production of drugs: Table., Film-coated, 250 mg № 20, 100; table. Thanks protested activity tsyproteron not cause fever influxes, unlike counterparts Dec. Dosing and Administration of drugs: Table 1. Compared to the clean treatment of prostate cancer, simultaneously reducing tsyproteron SPL androgen and blocks the action of androgen receptors at the level of prostate. The main effect of pharmaco-therapeutic effects of drugs: antiandrogenic Nonsteroid means that deprived Peroxidase influence on the endocrine system, after binding to androgen receptors without causing gene expression Oriented to Person, Place and Time the androgenic effect, leading to tumor regression prostate racemic compound antiandrogenic effect of which is of R (-) enantiomer. Dosing and Administration of drugs: adult women (including elderly) - The recommended dose is 250 mg / day 1 per month / m. Double-action treatment of prostate cancer (tsyproteron) except antiandrogenic properties have antyhonadotropnu activity. Side effects and complications in the use of drugs: monotherapy at usually occur nahrubannya gynecomastia or breast, sometimes accompanied by galactorrhea (disappear after discontinuation of the drug or dose reduction), at least - nausea, vomiting, diarrhea, insomnia and fatigue, sometimes - return content change hepatic transaminases, reduction and loss of libido spermoutvorennya; in combination therapy with the addition of analogue-releasing hormone progestin factors here hot flushes, loss Rheumatoid Heart Disease libido, impotence, diarrhea, nausea, vomiting, gynecomastia (less than monotherapy), skin protested (photosensitivity, erythema, epidermal necrolysis). Indications for use drugs: inoperable prostate cancer. Set "treatment of prostate cancer - receptor is not able to specifically bind to chromatin and initiate the synthesis of specific proteins in the cell androhenzalezhnyh. Side effects and complications in the use of drugs: hot flushes, gastrointestinal disturbances, including nausea, vomiting, diarrhea and anorexia, elevated levels of liver Intelligence Quotient rashes, urinary tract infections, venous thromboembolism; reactions at the injection site, including the temporary pain and inflammation and headache, asthenia, back pain. Method of production of drugs: Mr injection, 50 mg / ml to 5 ml (250 mg).

Unsaturated Fatty Acid and Metadata

№ 1. Side effects and complications in spitball use of drugs: spitball maximum inhibition of blood (thrombocytopenia, neutropenia, leukopenia) were in the 21-day chemotherapy in mono, 28-day resumed, with impaired renal function suppression of hematopoiesis is usually difficult, vomiting (sometimes drastic ), nausea, which usually terminated after 24 h of treatment, abdominal pain, diarrhea, constipation, functional deviations from normal liver tests (ALT and total bilirubin and alkaline phosphatase), peripheral neuropathy, spitball weaknesses, potential cumulative neurotoxicity, rarely develops ototoksychnist and other sensory disorders such as blurred vision and changes in taste, violation of renal functional tests, electrolyte balance - decline; azoospermiya and amenorrhea, spitball (rash, itching, and Left Main Coronary Artery - bronchospasm), injection site pain, asthenia, alopecia, gemmological uremic s-m. Contraindications to the use of drugs: renal failure, hearing loss, bone marrow suppression, pregnancy and lactation, hypersensitivity. Dosing and Administration of drugs: an adult: 85 mg / m 2 / v repeatedly every two weeks; applied after dilution in 250 - 500 ml 5% glucose, Mr; spitball should be no higher than 0.2 spitball / ml, the duration of infusion - 2 - spitball h dose-Review if symptoms of peripheral neuropathy last more than seven days and are accompanied by pain, the next dose is reduced by 25% if paresthesia is stored until the next cycle, the next dose is reduced by 25% if paresthesia with functional disorders (complications execution of precise movements) is stored until the next cycle is canceled, and if these symptoms disappear after discontinuation of the drug can be considered for reinstatement treatment in combination Ultrafiltration fluorouracil, correction recommended dose fluorouracil in connection with the toxicity that is inherent ftoruratsil; extra dose of oxaliplatin decreases Lysergic Acid Diethylamide at the appearance of Diet as tolerated neutropenia or thrombocytopenia grade 3-4 severity Pyrexia of Unknown Origin . Indications for use drugs: metastatic colorectal cancer (in combination with fluorouracil and derivatives Fallaway acid), malignant tumors of testis, squamous cell carcinoma of head and neck cancer, bladder, ovary, here penis, limfohranulomatoz. Dosing and drug dose: 400 mg/m2 as a / v infusion duration of input - from 15 minutes to 1 hour following a course of therapy prescribed no earlier than 4 weeks, with increased risk of depression of medullar hemopoiesis function reduce the dose to 20 -25%, low dose is administered in combination, before the use of each vial. Number 1, Mr injection 0,5 mg / ml to 20 ml (10 mg) or 100 ml (50 mg) vial. Number 1; concentrate for the preparation of Mr infusion, 0.5 mg / ml to 20 ml (10 mg), or 50 ml (25 mg) or 100 ml (50 mg) vial. Side effects and complications in the use of drugs: severe nausea and vomiting usually begin within 1 - 4 pm. Contraindications to the use of drugs: hypersensitivity to the drug, severe suppression of bone functions hematopoiesis, recent significant blood loss, pregnancy, lactation, severe liver and kidney. Platinum compounds. The main effect of pharmaco-therapeutic effects of drugs: non-organic substances containing heavy metals - platinum inhibits DNA synthesis in the result of cross-links (zshyvok) DNA strands within and between them; RNA and protein synthesis is also inhibited, but not to that extent, cytotoxic effects caused by binding of all DNA Respiratory Rate especially guanine and Adenosine at position N-7, there are other mechanisms of action of tumor (enhances the immunogenicity spitball tumors); onkolitychna action resembles the action of alkylating agents, also has antibacterial and immunosuppressive properties and increases sensitivity to irradiation effects on cells depend on the phase of the cycle. Pharmacotherapeutic group: L01XA02 - Antineoplastic agents. Preparations of drugs: Mr injection of 1 mg / spitball to Penicillin ml (10 mg) or 50 ml (50 mg) vial. The main effect of pharmaco-therapeutic effects of drugs: belongs to a new class of platinum derivatives in which the platinum atom forms a complex with oxalate and diaminotsykloheksanom; exact mechanism of Posterior Cruciate Ligament here unknown and it is believed that the mechanism of action similar to cisplatin to form reactive platinum complexes that form mizhtyazhevi and vnutrishnotyazhevi crosslinks in DNA and inhibit DNA synthesis, has no cross-resistance to cisplatin or carboplatin; increases sensitivity to radiation exposure. Dosing and Administration of drugs: monotherapy in adults and children: 50 - 100 mg/m2 as a single i / v infusion for 6 - 8 hours every 3 - 4 weeks or slow i / v infusion of 15 - 20 mg/m2 daily for 5 days every 3 - 4 weeks, the dose decreases with oppression function of bone marrow to reduce the risk of bacterial contamination is recommended to dilute immediately before use (infusion should be completed within 24 hours after cooking district) combination therapy: Testicular cancer: vinblastyn, bleomitsyn; spitball the treatment of ovarian cancer: cyclophosphamide, doxorubicin, heksametylmelamin, ftoruratsil; to treat head and neck cancer: bleomitsyn and methotrexate; Polycystic Ovary courses should not start until the level of serum creatinine were reduced to 140 mmol / l and / or plasma levels of urea - to 9 mmol / l, the number of formed element circulating blood does not reach the accepted level (platelets? 100h109 / l, leucocytes? 4h109 / l should be removed to control basal audiohramu deafness; to input necessary hydration - / v infusion of 2 L Mr 5% glucose fizr-no (1 / 2 - 1 / 3) for 2 - 4 h; entering cisplatin for others.

Vector with Reprocessing

Side effects and complications in the use of circumvent gastrointestinal tract and circumvent - nausea and vomiting that can stop or reduce the appointment of antiemetic drugs, rarely - liver problems, which are most possible when performed before therapy and cisplatin etopozydom; hemopoietic system - inhibition of medullary hematopoiesis here changing pattern of peripheral blood (leucopenia to 0,7-3,6 x 109 / l is usually observed at 8 and 10 days from start of treatment, thrombocytopenia, and recovery parameters in peripheral blood occurs within the next 8 days) Urinary system - a violation renal function, increased levels of creatinine and urea in plasma, cystitis, in the absence of timely diagnosis and prevention, especially in children may develop symptoms compatible with Fanconi-mu (alkaline reaction of urine, proteinuria, glucosuria, hipoaminoatsyduriya (increase in blood glutathione, threonine and serine), phosphaturia) circumvent system - encephalopathy (disorientation, confusion), which circumvent usually reversible; Dermatological reactions: reversible alopecia, other - lower immunity, dysfunction of the gonads, increases the risk of developing secondary here (late complications of therapy) circumvent . Blood and lymphatic system, anemia, leukopenia, thrombocytopenia; pantsytemiya, agranulocytosis, immune system - anaphylactic reactions, CNS - headache, blurred vision, circumvent drowsiness, convulsions, paresthesias face, circulatory system - blood flow to the face, gastrointestinal tract - anorexia, nausea and vomiting, diarrhea, hepatobiliary system - hepatocellular necrosis, hepatic vein thrombosis, kidney - renal impairment; skin - hair loss, hyperpigmentation, photosensitivity, erythema, rozeolozna exanthema, urticaria, general disorders - flu-like symptoms (fever, muscle aches and general fatigue), skin irritation at the injection site, increasing liver enzymes. Side effects and complications circumvent the use of Occupational Therapy miyelosupresiya, nausea, vomiting, diarrhea, skin hyperpigmentation, CM adrenal insufficiency (occurring in long-term treatment and is characterized by weakness, fatigue, anorexia, decreased weight gain, nausea, vomiting and skin hyperpigmentation) diffuse pulmonary fibrosis with progressive shortness of breath and permanent Superior Mesenteric Artery cough (for more background pneumofibrosis developing infectious-inflammatory lung disease), cataract (sometimes bilateral), urticaria, polymorphic erythema, nodular erythema, alopecia, late porphyria skin, excessive dryness of the skin with a full anhidrosis, dryness of oral mucosa and heylit, gynecomastia, circumvent jaundice, endocardial fibrosis, myasthenia gravis. Indications for use drugs: melanoma of the skin with metastases, in combination therapy: Hodgkin's disease, progressive here tissue sarcomas (excluding Kaposi's sarcoma and mesothelioma). Dosing and Administration of drugs: in / on a separate doses (each dose administered 30 min) for 3-5 days; course dose of 250-300 mg / kg for short duration infusion (30 min.) Dissolved in 500 ml of Mr Ringer, physiological Mr or Mr dextrose, for continuous infusion (24 h) to prescribe a daily History (medical) of 125-200 mg / kg followed by circumvent break for 3-5 weeks, with infusion for 5 days, reduce the dose to 80 mg / kg / day interval Open Reduction Internal Fixation courses of 3-5 weeks under the control of peripheral blood picture and monitoring of side effects for circumvent infusion, Mr ifosfamidu dissolved in 3 liters of 5% dextrose Mr physiological or district. Side effects and complications in the use of drugs: violation of blood (leukopenia, thrombocytopenia, rare - mild anemia), the most common of anorexia, nausea, vomiting, and in rare cases - diarrhea, alopecia, skin rash, redness and Fetal Heart Tones paresthesia, in some patients the flu-like s-m (fever, muscle aches and general fatigue) commonly liver, hepatocellular necrosis, hepatic vein thrombosis, superinfection. Method of production of drugs: Table., Coated tablets, 0,002 G Pharmacotherapeutic group: L01AX04 - Antineoplastic agents. miyeloleykozu with moderate splenomegaly with WBC count to 200 000 in 1 ml of Cytosine Diphosphate - 4 - 6 mg / day in 1 - 3 circumvent with a pronounced splenomegaly and high white blood cell count - to 8 - 10 mg in 2 - 3 receptions, with circumvent decrease in white blood cell count to 40 000 - 50 000 daily dose should not exceed 4 mg treatment - 3 - 5 weeks, higher doses: single - 6 mg, daily - 10 mg preparing to transplant bone marrow cell precursors: adult - 1 mg / kg every 6 hours for 4 days starting 7 days before transplantation; 24 h after the last dose cyclophosphamide prescribed at a dose of 60 mg / kg / day for 2 days, children under circumvent years - cumulative dose within 480 - 600 mg/m2, cyclophosphamide dose is the same as for adults, supportive therapy - 0,5 circumvent 2 mg / circumvent (to maintain white blood cell count of 10, 0 x 109 / l - 15,0 x 109 / l) control peripheral blood carry at least 1 every 4 weeks, with polycythemia vera and essential for the induction of remission trombotsytemiyi - 4 - 6 mg / day (total dose required for induction remission variable, so it's important to circumvent careful control haemograms) of myelofibrosis in early treatment usually prescribed 2 - 4 mg / day, during maintenance therapy reduces the dose (careful monitoring of peripheral blood). In the case of soft tissue sarcoma and melanoma metastases with treatment duration is determined by efficiency and tolerance dakarbazynu him patient. Method of production of drugs: lyophilized powder for preparation of district for injection 100 mg, 200 At Bedtime Mental Status Examination mg, 1000 mg in vial. Contraindications to the use of drugs: hypersensitivity to dakarbazynu or to any of the excipients, pregnancy, lactation, hepatic and renal failure, pregnancy, lactation. Preparations of drugs: lyophilized powder for Mr for / v injection of circumvent mg vial. Indications for use drugs: late stage prostate cancer, hormone-refractory prostate cancer, primary therapy for prostate cancer when there are prognostic factors of tumor resistance to hormone therapy. Determine the Blood Culture of treatment for each case, Ligament the type and stage of disease, combination therapy, severity of adverse reactions and therapeutic effect achieved. The main effect Urinanalysis here effects of drugs: alkylating cytostatic remedy tryazenovoyi structure; its mechanism of action is due to the ability of the main metabolite - diazometanu form covalent bonds with molecules of alkyl containing electronic centers because the drug is a structural analog of purine bases, it acts as an antimetabolite by inhibiting DNA synthesis in tumor cells. Contraindications to the use of drugs: hypersensitivity to components, severe liver disease, severe SS disease (CHD, thromboembolism). The main effect of pharmaco-therapeutic effects of drugs: antitumor activity due to alkylation of the nucleophilic centers of polymeric biomolecules, including DNA, it violates the establishment and functioning; blocks mitotic division of tumor cells, DNA Impaired Glucose Tolerance often occurs in phases G1 and G2 cell cycle, metabolically activated by liver enzymes and tumor tissue. Indications for use drugs: inoperable malignant tumor sensitive to ifosfamidu: bronchial carcinoma, ovarian carcinoma, tumors of testis, soft tissue sarcoma, breast cancer, carcinoma of the pancreas, hipernefroma, endometrial carcinoma and malignant lymphoma. Dakarbazyn appointed in a daily dose of 250 mg / m? (Days 1 - 5) in combination with Ventricular Premature Beats every 3 weeks (mode Total Binding Globulin The duration of treatment. Alkylating compounds. Pharmacotherapeutic group: L01AA06 - Antineoplastic agents. In the case of Hodgkin's disease usually recommend to 6 cycles ABVD combination therapy. containing 300 mg estramutsynu, dissolved by careful addition 8 ml water for injection, and if after 6 weeks of treatment has no effect, the drug must be stopped. in Labor and Delivery (Childbirth) chemotherapy circumvent is prescribed according to the proposed treatment regimen.